The Patent Finder

Anygen Co., Ltd.

Also on record
Records under this name other than the patents Anygen Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Showing 1 to 5 of 5 · Back to Anygen Co., Ltd.

PatentTitleStatus Expires Confidence
US 8,859,783INDIRUBIN-3'-Oxime Derivatives as Potent Cyclin Dependent Kinase Inhibitors
Lapsed on the fee record
Ended Oct 14, 2026 · High confidence
Lapsed on the fee recordEnded Oct 14, 2026High confidence
US 7,572,923Indirubin derivatives having anticancer property against human cancer cell line
Term ended
Term ended May 2, 2025 · From the USPTO record
Term endedTerm ended May 2, 2025From the USPTO record
US 8,673,856Omega conotoxins
Lapsed on the fee record
Ended Mar 18, 2022 · From the USPTO record
Lapsed on the fee recordEnded Mar 18, 2022From the USPTO record
US 9,556,242Method for Regulating Circadian Rhythms
Lapsed on the fee record
Ended Jan 31, 2021 · High confidence
Lapsed on the fee recordEnded Jan 31, 2021High confidence
US 7,812,177Potassium channel opener having benzofuroindole skeleton
Lapsed on the fee record
Ended Oct 12, 2018 · From the USPTO record
Lapsed on the fee recordEnded Oct 12, 2018From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited